ArticleFrontiers in pharmacology2022

Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression.

Ming Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.